Report Categories Report Categories

Report Categories

industry Category

All

Total: 4 records, 1 pages

Global Short-acting Recombinant Human Erythropoietin Drugs Supply, Demand and Key Producers, 2024-2030

date 06 Mar 2024

date Pharma & Healthcare

new_biaoQian Short-acting Recombinant Human Erythropoietin Drugs

The global Short-acting Recombinant Human Erythropoietin Drugs market size is expected to reach $ 14300 million by 2030, rising at a market growth of 6.1% CAGR during the forecast period (2024-2030).

USD4480.00

Add To Cart

Add To Cart

Global Short-acting Recombinant Human Erythropoietin Drugs Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030

date 19 Jan 2024

date Pharma & Healthcare

new_biaoQian Short-acting Recombinant Human Erythropoietin Drugs

According to our (Global Info Research) latest study, the global Short-acting Recombinant Human Erythropoietin Drugs market size was valued at USD 9433.4 million in 2023 and is forecast to a readjusted size of USD 14300 million by 2030 with a CAGR of 6.1% during review period.

USD3480.00

Add To Cart

Add To Cart

Global Short-acting Recombinant Human Erythropoietin Drugs Supply, Demand and Key Producers, 2023-2029

date 21 Oct 2023

date Pharma & Healthcare

new_biaoQian Short-acting Recombinant Human Erythropoietin Drugs

The global Short-acting Recombinant Human Erythropoietin Drugs market size is expected to reach $ 14300 million by 2029, rising at a market growth of 6.1% CAGR during the forecast period (2023-2029).

USD4480.00

Add To Cart

Add To Cart

Global Short-acting Recombinant Human Erythropoietin Drugs Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029

date 21 Oct 2023

date Pharma & Healthcare

new_biaoQian Short-acting Recombinant Human Erythropoietin Drugs

According to our (Global Info Research) latest study, the global Short-acting Recombinant Human Erythropoietin Drugs market size was valued at USD 9433.4 million in 2022 and is forecast to a readjusted size of USD 14300 million by 2029 with a CAGR of 6.1% during review period.

USD3480.00

Add To Cart

Add To Cart

The global Short-acting Recombinant Human Erythropoietin Drugs market size is expected to reach $ 14300 million by 2030, rising at a market growth of 6.1% CAGR during the forecast period (2024-2030).

USD4480.00

addToCart

Add To Cart

According to our (Global Info Research) latest study, the global Short-acting Recombinant Human Erythropoietin Drugs market size was valued at USD 9433.4 million in 2023 and is forecast to a readjusted size of USD 14300 million by 2030 with a CAGR of 6.1% during review period.

USD3480.00

addToCart

Add To Cart

The global Short-acting Recombinant Human Erythropoietin Drugs market size is expected to reach $ 14300 million by 2029, rising at a market growth of 6.1% CAGR during the forecast period (2023-2029).

USD4480.00

addToCart

Add To Cart

According to our (Global Info Research) latest study, the global Short-acting Recombinant Human Erythropoietin Drugs market size was valued at USD 9433.4 million in 2022 and is forecast to a readjusted size of USD 14300 million by 2029 with a CAGR of 6.1% during review period.

USD3480.00

addToCart

Add To Cart